Medicare Enrolled
Dr. Kumar Sanam, M.B.B.S.
Cardiovascular Disease · Fresno, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Research-focused
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sanam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sanam?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sanam
Dr. Kumar Sanam is a cardiovascular disease specialist in Fresno, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Sanam performed 2,120 Medicare services across 1,814 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sanam received a total of $41,482 from 42 pharmaceutical and/or device companies across 300 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are classified as research and scientific activities (grants and research funding). Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sanam is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 47% volume in CA
$41,482 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,120
Medicare services
Top 47% in CA for cardiovascular disease
1,814
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~141 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
909 | $6 | $116 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
144 | $134 | $400 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
120 | $41 | $90 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
117 | $12 | $57 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
105 | $144 | $350 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
103 | $103 | $275 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
77 | $164 | $700 |
| Cardiac catheterization | 76 | $187 | $800 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
70 | $10 | $30 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
58 | $47 | $250 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
51 | $96 | $250 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
47 | $126 | $375 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
44 | $54 | $292 |
| New patient office visit, complex (60-74 min) | 31 | $180 | $475 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
29 | $379 | $975 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
27 | $71 | $300 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
26 | $408 | $1,450 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
21 | $2 | $10 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
15 | $11 | $40 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 15 | $260 | $975 |
| Aortography with contrast and radiologist review An imaging procedure using contrast dye to visualize the aorta above the heart valve, including professional review by a radiologist. |
13 | $29 | $120 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
11 | $79 | $340 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
11 | $13 | $56 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.0% high complexity
15.3% medium
75.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$41,482
Total received (2018-2024)
Avg $5,926/year across 7 years
Top 11% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
300
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Scientific / Research
Research funding and grants
$16,962 (40.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,367 (37.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$9,152 (22.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,321
2023
$3,989
2022
$774
2021
$23,121
2020
$4,417
2019
$2,821
2018
$1,040
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Penumbra, Inc.
$2,443
ABIOMED
$909
ShockWave Medical, Inc
$628
Amgen Inc.
$284
Medtronic, Inc.
$225
Edwards Lifesciences Corporation
$223
E.R. Squibb & Sons, L.L.C.
$99
Boston Scientific Corporation
$79
SCPHARMACEUTICALS INC.
$62
Boehringer Ingelheim Pharmaceuticals, Inc.
$61
CVRx, Inc.
$58
Novartis Pharmaceuticals Corporation
$58
AstraZeneca Pharmaceuticals LP
$25
Kestra Medical Technology Services, Inc.
$25
Daiichi Sankyo Inc.
$24
Abbott Laboratories
$23
Kiniksa Pharmaceuticals International, plc
$21
iRhythm Technologies, Inc.
$20
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$20
Novo Nordisk Inc
$18
PFIZER INC.
$15
Top 3 companies account for 74.8% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$19,116
Boehringer Ingelheim Pharmaceuticals, Inc.
$6,785
Medtronic Vascular, Inc.
$2,891
Penumbra, Inc.
$2,443
AstraZeneca Pharmaceuticals LP
$1,894
Edwards Lifesciences Corporation
$1,604
ABIOMED
$1,541
Lilly USA, LLC
$712
Amgen Inc.
$697
ShockWave Medical, Inc
$628
Abbott Laboratories
$496
Inari Medical, Inc.
$397
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$347
E.R. Squibb & Sons, L.L.C.
$338
Novartis Pharmaceuticals Corporation
$180
BOSTON SCIENTIFIC CORPORATION
$145
Janssen Pharmaceuticals, Inc
$142
Boston Scientific Corporation
$140
Cardiovascular Systems Inc.
$124
Biosense Webster, Inc.
$109
SCPHARMACEUTICALS INC.
$101
CVRx, Inc.
$92
Astellas Pharma US Inc
$87
PFIZER INC.
$85
SANOFI-AVENTIS U.S. LLC
$35
W. L. Gore & Associates, Inc.
$27
Philips Electronics North America Corporation
$26
Kiniksa Pharmaceuticals, Ltd.
$25
Kestra Medical Technology Services, Inc.
$25
Esperion Therapeutics, Inc.
$25
Daiichi Sankyo Inc.
$24
Gilead Sciences, Inc.
$21
Kiniksa Pharmaceuticals International, plc
$21
Chiesi USA, Inc.
$20
iRhythm Technologies, Inc.
$20
AngioDynamics, Inc.
$19
Novo Nordisk Inc
$18
Bayer Healthcare Pharmaceuticals Inc.
$17
Regeneron Healthcare Solutions, Inc.
$16
Actelion Pharmaceuticals US, Inc.
$16
Terumo Medical Corporation
$16
Kowa Pharmaceuticals America, Inc.
$12
Top 3 companies account for 69.4% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Undivided · ALPHAVAC · AMPLATZER TALISMAN · ANDEXXA · AZURE XT DR MRI SURESCAN · Adempas · AngioSeal · Arcalyst · Assure WCD · BRILINTA · Barostim Neo System · CAMZYOS · CG FUTURE · CHANTIX · COBALT DR MRI SURESCAN · COREVALVE EVOLUT R · COROFLOW · ClosureFast · Corlanor · Diamondback Coronary · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · Emerge Push · FARXIGA · FFRANGIO · FLOWTRIEVER CATHETER · FUROSCIX · GORE CARDIOFORM Septal Occluder · INJECTAFER · Impella · Indigo System · JARDIANCE · KENGREAL · LEQVIO · LEXISCAN · LifeVest · Livalo · MITRACLIP · MULTAQ · NA · NEXLETOL · OPSUMIT · Onyx · PRADAXA · PRALUENT · RESOLUTE ONYX · Repatha · Resolute · S · SAPIEN 3 Ultra RESILIA · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · VALIANT CAPTIVIA · VenaSeal · VersaCross Steerable Access Solution · WATCHMAN · XARELTO · XIENCE SKYPOINT · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (41%) are classified as scientific/research, suggesting involvement in clinical studies, grants, or innovation-related work.
Geographic Context
Cardiologists within 10 mi
41
Per 100K population
4.1
County median income
$71,434
Nearest hospital
SAINT AGNES MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sanam is a mixed practice specialist, with moderate Medicare volume, with research-focused industry engagement in the top 11% of CA peers, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sanam experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Sanam performed 909 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sanam receive payments from pharmaceutical companies?
Yes. Dr. Sanam received a total of $41,482 from 42 companies across 300 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sanam's costs compare to other cardiologists in Fresno?
Dr. Sanam's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sanam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Fresno
Browse cardiologists in Fresno ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology